Malignant Acanthosis Nigricans, Florid Cutaneous Papillomatosis and Tripe Palms Syndrome Associated with Gastric Adenocarcinoma - a Case Report

1. Rogers DL. Acanthosis nigricans. Semin Dermatol 1991;10:160-3.Search in Google Scholar

2. Schwartz RA. Acanthosis nigricans. J Am Acad Dermatol 1994;31(1):1-19.10.1016/S0190-9622(94)70128-8Search in Google Scholar

3. Kalus AA, Chien AJ, Olerud JE. Diabetes mellitus and other endocrine diseases. In: Wolf K, Goldsmith LA, Katz SI, Gilchrist BA, Paller AS, Leffell DJ, editors. Fitzpatrick’s dermatology in generale medicine. 7^th edition. New York: Mc Graw Hill Med; 2008. p. 1461-70.Search in Google Scholar

4. Olek-Hrab K, Silny W, Zaba R, Osmola-Mankowska A, Machiewicz-Wysocka M, Danczak-Pazdrowska A. Co-occurrrence of acanthosis nigricans and bladder adenocarcinoma - case report. Contemp Oncol (Pozn) 2013;17(3):327-30.Search in Google Scholar

5. Phiske MM. An approach to acanthosis nigricans. Indian Dermatol Online J 2014;5(3):239-49.10.4103/2229-5178.137765414420625165638Search in Google Scholar

6. Barbato MT, Criado PR, Silva AK, Averbeck E, Guerine MB, Sa NB. Association of acanthosis nigricans and skin tags with insulin resistence. An Bras Dermatol 2012;87(1):97-104.10.1590/S0365-0596201200010001222481657Search in Google Scholar

7. Munoz-Perez MA, Camacho F. Acanthosis nigricans: a new cutaneous sign in sever atopic dermatitis and Down syndrome. J Eur Acad Dermatol Venereol 2001;15:325-7.10.1046/j.1468-3083.2001.00239.xSearch in Google Scholar

8. Ceylan C, Alper S, Kilinc I. Leser-Trelat sign. Int J Dermatol 2002;41:687-8.10.1046/j.1365-4362.2002.01600.x12390193Search in Google Scholar

9. Pollitzer S. Acanthosis nigricans. In: Unna PG, Morris M, Besnier E, et al, editors. International atlas of rare skin disease. London: HK Lewis and Co; 1891. Chapter 10; p. 1-3.Search in Google Scholar

10. Janovsky V. Acanthosis nicricans. In: Unna PG, Morris M, Besnier E, et al, editors. International atlas of rare skin diseases. London; HK Lewis and Co; 1891. Chapter 11; p. 4-5.Search in Google Scholar

11. Brown J, Winkelmann RK. Acanthosis nigricans: a study of 90 cases. Medicine (Baltimore) 1968;47:33-51.10.1097/00005792-196801000-00002Search in Google Scholar

12. Curth HO. The necessity of distinguishing four types of acanthosis nigricans. In: Jadassohn W, Schirren CG, editors. Proceedings of XIII International Congress of Dermatology; 1967 Jul 31-Aug 5; Munchen, Germany. Berlin: Springer–Verlag; 1968. p. 557-8.Search in Google Scholar

13. Van Hagen P, Wijnhoven BPL, Torcque LA, Tilanus HW, van Lanschort JJB, Prens EP. Paraneoplastic acanthosis nigricans, Leser-Trelat and tripe palms associated with gastroesophageal junction adenocarcinoma: a case report. J Med Cas 2011;2(5):197-200.Search in Google Scholar

14. Pavithran K, Karunakaran M, Palit A. Disorders of keratinisation. In: Valia RG, Ameet RV, editors. IADVL textbook of dermatology. 3^rd ed. Munmbai: Bhalani Publ House; 2008. p. 1009-11.Search in Google Scholar

15. Kondo Y, Umegaki N, Terao M, Murota H, Kimura T, Karayama I. A case of generalized acanthosis nigricans with positive lupus erythematosus-related autoantibodies and antimicrosomal antibody: autoimmune acanthosis nigricans? Case Rep Dermatol 2012;4(1):85-91.Search in Google Scholar

16. Sawatkar GU, Dogra S, Bhadada SK, Kanwar AJ. Acanthosis nigricans – an uncommon cutaneous adverse effects of a common medication: report of two cases. Indian J Dermatol Venereol Leprol 2013;79:553.10.4103/0378-6323.11311223760338Search in Google Scholar

17. Erickson L, Lipschutz DE, Wrigley W, Kearse WO. A peculiar cutaneous reaction to repeated injections of insulin. JAMA 1969;209:934-5.10.1001/jama.1969.03160190056019Search in Google Scholar

18. Brinca A, Cardoso JC, Brites MM, Tellechea O, Figueiredo A. Florid cutaneous papillomatosis and acanthosis nigricans maligna revealing gastric adenocarcinoma. An Bras Dermatol 2011;86(3):573-7.10.1590/S0365-05962011000300025Search in Google Scholar

19. Andreev VC. Malignant acanthosis nigricans. Semin Dermatol 1984;3:265-72.Search in Google Scholar

20. Ortega-Loayza AG, Ramos W, Gutierrez EL, Paz PC, Bobbio L, Galarza C. Cutaneous manifestations of internal malignancies in tertiary health care hospital of a developing country. An Bras Dermatol 2010;85:736-42.10.1590/S0365-0596201000050002621152807Search in Google Scholar

21. DeWitt CA, Buescher LS, Stone SP. Cutaneous manifestations of internal malignant diseases: cutaneous paraneoplastic syndromes. In: Wolf K, Goldsmith LA, Katz SI, Gilchrist BA, Paller AS, Leffell DJ, editors. Fitzpatrick’s dermatology in general medicine. 7^th edition. New York: Mc Graw Hill Med; 2008. p. 1493-507.Search in Google Scholar

22. Jakubovic BD, Sawires HF, Adam DN. Occult cause of paraneoplastic acanthosis nigricans in a patient with known breast DCIS: case and review. Curr Oncol 2012;19(4):e299-302.10.3747/co.19.997Search in Google Scholar

23. Abu-Safieh Y, Khelfa S. Acanthosis nigricans: aA presentation of gastric adenocarcinoma. Arab J Gasroenterol 2011:12:156-7.10.1016/j.ajg.2011.04.001Search in Google Scholar

24. Braverman IM. Skin manifestations of internal malinancy. Clin Geriatr Med 2002;18(1):1-19.10.1016/S0749-0690(03)00031-4Search in Google Scholar

25. Scully C, Hegarty A. The oral cavity and lips. In: Burns T, Breathnac H, Cox N, Griffiths C, editors. Rook’s textbook of dermatology. Oxford: Wiley-Blackwell; 2010; Chapter 69.10.1002/9781444317633.ch69Search in Google Scholar

26. Soto Ortiz JA, Amezcua Rosas G, Guardado Luevanos I, Bologna Molina R. Acanthosis nigricans. Manifestaciones bucales. Dermatol Rev Mex 2011;55(1):47-50.Search in Google Scholar

27. Swineford SL, Drucker CR. Palliative treatment of paraneoplastic acanthosis nigricans and oral florid papillomatosis with retinoids. J Drugs Dermatol 2010;9(9):1151-3.Search in Google Scholar

28. Schulmann K, Strate K, Pox CP, Wieland U, Kreuter A. Paraneoplastic acanthosis nigricans with cutaneous and mucosal papillomatosis preceding recurrence of a gastric adenocarcinoma. J Clin Oncol 2012;30(32):e325-6.10.1200/JCO.2012.42.545423008315Search in Google Scholar

29. Amjad M, Arfan-ul-Bari, Shah AA. Malignant acanthosis nigricans: an early diagnostic clue. J Coll Physicians Surg Pak 2010;20(2):127-9.Search in Google Scholar

30. Pentenero M, Carrozzo M, Pagano M, Gandolfo S. Oral acanthosis nigricans, tripe palms and sign of Leser-Trelat in a patient with gastric adenocarcinoma. Int J Dermatol 2004;43:530-2.10.1111/j.1365-4632.2004.02159.x15230897Search in Google Scholar

31. Mukai T. Acanthosis nigricans. Acta Derm (Kyoto) 1929;14:447-60.Search in Google Scholar

32. Lenzner U, Ramsauer J, Petzoldt W, Meigel W. Acanthosis nigricans maligna. Case report and review of the literature. Hautarzt 1998;49:41-7.10.1007/s0010500506999522192Search in Google Scholar

33. Nair PS, Moorthy P, Suprakasan S, Jayapalan S, Sarin M. Malignant acanthosis nigricans with liver secondaries from an occult primary adenocarcinoma of gastrointestinal tract. Indian J Dermatol Venereol Leprol 2005;71(3):197-8.10.4103/0378-6323.1623916394413Search in Google Scholar

34. Kleikamp S, Bohm M, Frosch P, Brinkmeier T. Acanthosis nigricans, papillomatosis mucosae aund „tripe palms“ in a patient with metastasized carcinoma. Dtsch Med Wochenschr 2006;131(21):1209-13.10.1055/s-2006-94175316721709Search in Google Scholar

35. Oh CW, Yoon J, Kim CY. Malignant acanthosis nigricans associated with ovarian cancer. Case Rep Dermatol 2010;2(2):103-9.10.1159/000317116291437020689633Search in Google Scholar

36. Kaminska-Winciorek G, Brzezinska-Wcislo L, Lis-Swiety A, Krauze E. Paraneoplastic type of acanthosis nigricans in patient with hepatocellular carcinoma. Adv Med Sci 2007;52:254-6.Search in Google Scholar

37. Lazzarini R, Simone K, Queiroz G, Courral I, Magliari ME, Feder CK, et al. Acantose nigricante maligna: realato de caso. Dermatol Online J 2014;20(4):22377.10.5070/D3204022377Search in Google Scholar

38. Costa MC, Martinez NS, Belicha MG, Leal F. Acanthosis nigricans and ”tripe palm” as paraneoplastic manifestations of metastatic tumor. An Bras Dermatol 2012;87(3):498-500.10.1590/S0365-05962012000300030Search in Google Scholar

39. Yang YH, Zhang RZ, Kang DH, Zhu WY. Three paraneoplastic signs in the same patient with gastric adenocarcinoma. Dermatol Online J 2013;19(7):18966.10.5070/D3197018966Search in Google Scholar

40. Stawczyk-Macieja M, Szczerkowska-Dobosz A, Nowicki R, Majewska H, Dubovik M, Sokolowska-Wojdylo M. Malignant acanthosis nigricans, florid cutaneous papillomatosis and tripe palms syndrome associated with gastric adenocarcinoma. Postepy Dermatol Alergol 2014;31(1):56-8.10.5114/pdia.2014.40663395205924683401Search in Google Scholar

41. Kebria MM, Belinson J, Kim R, Mekhail TM. Malignant acanthosis nigricans, tripe palms and sign of Leser-Trelat, a hint to the diagnosis of early stage ovarian cancer: a case report and review of the literature. Gynecol Oncol 2006;101(2):353-5.10.1016/j.ygyno.2005.12.02416443260Search in Google Scholar

42. Schwartz RP, Burgess GH. Florid cutaneous papillomatosis. Arch Dermatol 1978;114:1803-6.10.1001/archderm.1978.01640240045015Search in Google Scholar

43. White H. Acanthosis nigricans and wart like lesions associated with metastatic carcinoma of the stomach. Cutis 1976;17:931-3.Search in Google Scholar

44. Gross G, Pfister H, Hellenthal B, Hagedom M. Acanthosis nigricans maligna. Clinical and virological investigations. Dermatologica 1984;168:265-72.10.1159/000249721Search in Google Scholar

45. Breathnach SM, Wells GC. Acanthosis palmaris: tripe palms. A distinctive pattern of palmar keratoderma frequently associated with internal malignancy. Clin Exp Dermatol 1980;5:181-9.10.1111/j.1365-2230.1980.tb01686.x6449322Search in Google Scholar

46. Cohen PR, Grossman ME, Almeida L, Kurzrock R. Tripe palms and malignancy. J Clin Oncol 1989;7:669-78.10.1200/JCO.1989.7.5.6692651581Search in Google Scholar

47. Koulaouzidis A, Leiper K. Tripe palms or acanthosis palmaris. Intern Med J 2007;37:502.10.1111/j.1445-5994.2007.01374.x17547729Search in Google Scholar

48. Saeed H, Massarweh S. Images in clinical medicine. Hypertrophic pulmonary osteoarthropathy and tripe palms. N Engl J Med 2012;366(4):360.10.1056/NEJMicm111086222276825Search in Google Scholar

49. Cox NH, Coulsin IH. Systemic diseases and skin. In: Burns DA, Breathnach SM, Cox NH, Grifits CEM, editors. Rook’s textbook of dermatology. Oxford: Blackwell Publishing Ltd; 2010.Search in Google Scholar

50. Abreu Velez AM, Howard MS. Diagnosis and treatment of cutaneous paraneoplastic disorders. Dermatol Ther 2010;23:662-75.10.1111/j.1529-8019.2010.01371.x21054710Search in Google Scholar

51. Clarke J. Malignant acanthosis nigricans. Clin Exp Dermatol 1977;2:167-70.10.1111/j.1365-2230.1977.tb01561.x884896Search in Google Scholar

52. Moore RL, Devere TS. Epidermal manifestations of internal malignancy. Dermatol Clin 2008;26(1):17-29.10.1016/j.det.2007.08.00818023768Search in Google Scholar

53. Fabroni C, Gimma A, Cardinali C, Scocco GL. Tripe palms associated with malignant acanthosis nigricans in a patient with gastric adenocarcinoma: a case report and review of the literature. Dermatol Online J 2012;18(11):15.10.5070/D37BH1H290Search in Google Scholar

54. Heaphy MR, Millns JL, Schroeter AL. The sign of Leser-Trelat in a case of adenocarcinoma of the lung. J Am Acad Dermatol 2000;43(2 Pt 2):386-90.10.1067/mjd.2000.10496710901731Search in Google Scholar

55. Haase I, Hunzelmann N. Activation of epidermal growth factor receptor/ERK signaling correlates with suppressed differentiation in malignant acanthosis nigricans. J Invest Dermatol 2002:118(5):891-3.10.1046/j.1523-1747.2002.17631.x11982771Search in Google Scholar

56. Ghosh U, Thomas M, Mathai S. Syndrome of insulin resistance with acanthosis nigricans, acral hypertrophy and muscle cramps in an adolescent – a rare diagnosis revised. Indian J Pediatr 2014;81(12):1389-91.10.1007/s12098-014-1503-724912440Search in Google Scholar

57. Judge MR, M.Lean WHJ, Munro CS. Disorders of keratinisation. In: Burns DA, Breathnach SM, Cox NA, Griffits CEM, editors. Rook’s Textbook of Dermatology. Oxford: Blackwell Publishing Ltd; 2010. Chapter 19.10.1002/9781444317633.ch19Search in Google Scholar

58. Koyama S, Ikeda K, Sato M, Shibahara K, Yuhara K, Fukutomi H, et al. Transforming growth factor-alpha (TGF alpha)-producing gastric carcinoma with acanthosis nigricans: an endocrine effect of TGF alpha in the pathogenesis of cutaneous paraneoplastic syndrome and epithelial hyperplasia of the esophagus. J Gastroenterol 1997;32(1):71-7.10.1007/BF012132999058298Search in Google Scholar

59. Hida Y, Kubo Y, Nishio Y, Murakami S, Fukumoto D, Sayama K, et al. Malignant acanthosis nigricans with enhanced expression of fibroblast growth factor receptor 3. Acta Derm Venereol 2009;89:435-7.10.2340/00015555-0666Search in Google Scholar

60. Akovbyan VA, Talanin NI, Arifov SS, Tukhvatullina ZG, Musabayev AN, Baybekov IM, et al. Successful treatment of acanthosis nigricans with etretinate. J Am Acad Dermatol 1994;31:118-20.10.1016/S0190-9622(09)80242-9Search in Google Scholar

61. Bohm M, Luger TA, Metze D. Treatment of mixed-type acanthosis nigricans with topical calcipotriol. Br J Dermatol 1998;139:932-4.10.1046/j.1365-2133.1998.02538.x9893209Search in Google Scholar

62. Zayed A, Sobhi RM, Abdel Halim DM. Using trichloroacetic acid in the treatment of acanthosis nigricans: a pilot study. J Dermatol Treat 2014;25(3):223-5.10.3109/09546634.2012.67419422494198Search in Google Scholar